Matthew Whitman
Partner, Head of Origination at Arsenal Capital Partners
New York City, New York
Matthew Whitman, Partner, Head of Origination at Arsenal Capital Partners is an active investor based in New York City, New York. This profile covers what Matthew Whitman backs, at which stage, and how founders can reach out in 2026.
- Investor type
- VCPEInvestment Partner
- Stages
- SeedSeries ASeries BLate Stage Venture
- Invests in
- MedTech & Medical DevicesDigital Health & HealthTechHealthcare & BiotechBiotech & PharmaFintechConsumer & RetailMarketplace
- Location
- New York City, New York
- Typical check
- $2M
- Past investments
- 27
Notable investments
Cureatr
androsCartiva
WelldocHelpAround Medical
Nebula GenomicsTransactis
NeuSpera MedicalPersonal Genome Diagnostics
Science Exchange
CoravinHow to reach Matthew Whitman
Angels and operators like Matthew Whitman reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded Accelerator.
Connect with Matthew Whitman
Frequently Asked Questions
What does Matthew Whitman invest in?
Matthew Whitman invests in MedTech & Medical Devices, Digital Health & HealthTech, Healthcare & Biotech and Biotech & Pharma, typically at Seed, Series A, Series B and Late Stage Venture. Match your sector and stage, then reach out with a personalized pitch.
What stage does Matthew Whitman invest at?
Matthew Whitman typically invests at Seed, Series A, Series B and Late Stage Venture. Lead with traction that fits the stage when you reach out.
What is Matthew Whitman's typical check size?
Matthew Whitman typically writes checks around $2M. Use it as a signal for whether your raise fits their stage.
How do I contact Matthew Whitman?
Unlock Matthew Whitman's verified email on Round Funded Accelerator and send a personalized pitch. We surface only deliverable contacts so your outreach lands.